Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Stock Price Down 9.2% - Here's Why

Key Points

• Bayer Aktiengesellschaft's shares dropped by 9.2% during mid-day trading, reaching a low of $7.23, with trading volume declining significantly to 328,358 shares.
• Recent analyst ratings show mixed reviews for Bayer, with one firm upgrading the stock to a "strong-buy," while another downgraded it to "hold," resulting in an average rating of "Buy."
• The company reported earnings of $0.65 per share for the last quarter, exceeding expectations, with a revenue of $15.27 billion against estimates of $13.39 billion.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) dropped 9.2% during trading on Wednesday . The company traded as low as $7.23 and last traded at $7.23. Approximately 328,358 shares changed hands during trading, a decline of 59% from the average daily volume of 802,480 shares. The stock had previously closed at $7.96.

Analyst Ratings Changes

BAYRY has been the subject of a number of research analyst reports. Wall Street Zen raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a research note on Sunday. Hsbc Global Res raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, June 11th. Kepler Capital Markets raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a research report on Wednesday, June 11th. Finally, The Goldman Sachs Group raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research report on Thursday, June 5th. One equities research analyst has rated the stock with a hold rating, two have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Buy".

Bayer Aktiengesellschaft Stock Performance

The stock's 50-day moving average is $7.83 and its 200-day moving average is $6.75. The stock has a market cap of $29.59 billion, a price-to-earnings ratio of -7.76 and a beta of 0.91. The company has a current ratio of 1.25, a quick ratio of 0.79 and a debt-to-equity ratio of 1.07.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported $0.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.10. Bayer Aktiengesellschaft had a negative net margin of 7.61% and a positive return on equity of 15.48%. The company had revenue of $12.42 billion during the quarter, compared to the consensus estimate of $10.79 billion. On average, analysts expect that Bayer Aktiengesellschaft will post 1.31 EPS for the current year.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.